Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$136.53

0.53 (0.39%)

09:04
04/16/19
04/16
09:04
04/16/19
09:04

Johnson & Johnson says 'very pleased' with strong start to 2019

Says: Q1 results reinforce confidence in our business... Delivered above market performance globally in Pharmaceutical segment... We continue to invest in R&D at competitive levels... Our dividend will continue to be a key priority going forward... Sees currency headwinds in Q2, but not as severe as Q1. Comments from Q1 earnings conference call.

  • 16

    Apr

  • 25

    Apr

JNJ Johnson & Johnson
$136.53

0.53 (0.39%)

04/05/19
PIPR
04/05/19
NO CHANGE
Target $325
PIPR
Overweight
Piper a 'little cautious' on Q2 results for Cooper Companies
After speaking with a contact lens distributor, Piper Jaffray analyst Matt O'Brien is a "little cautious" on Cooper Companies' fiscal Q2 results. The shift to dailies continues, which is positive for the market as a whole, but Johnson & Johnson (JNJ) and Alcon were more aggressive in calendar Q1, so results for the category "may be a bit unusual," O'Brien tells investors in a research note. In addition to the "odd activity" from the two largest players, the analyst also heard about some "aggressive behavior" from Cooper in recent weeks, which makes him think the company should hit its numbers. He's still bullish on Cooper Companies capturing share in lenses in 2019 and 2020 and keeps an Overweight rating on the name.
04/08/19
PIPR
04/08/19
NO CHANGE
Target $20
PIPR
Overweight
Immunomedics deal with J&J indicates sacituzumab re-filing, says Piper Jaffray
Immunomedics (IMMU) this morning announced that it has entered into an agreement with Johnson & Johnson (JNJ) to provide detailing services to J&J for erdafitinib in the U.S. through Q1 of 2020, Piper Jaffray analyst Joseph Catanzaro tells investors in a research note. The analyst believes the deal will provide incremental revenue to Immunomedics while allowing the company to keep its sacituzumab-trained sales team on board while offsetting some of the costs. Further, the Q1 of 2020 termination suggests a potential timeline for a sacituzumab re-filing and approval, says Catanzaro, who notes Immunomedics has not yet provided guidance. The analyst remains comfortable with his mid-2020 approval timing for sacituzumab and keeps an Overweight rating on Immunomedics with a $20 price target.
04/09/19
NEED
04/09/19
UPGRADE
Target $3
NEED
Buy
Geron upgraded to Buy from Hold at Needham
Needham analyst Chad Messer upgraded Geron (GERN) to Buy with a price target of $3, saying the return of development rights for imetelstat in September by Janssen (JNJ) has created a "buying opportunity". The analyst cites the program's subsequent readouts from Phase II IMbark and IMerge studies in myelofibrosis and myelodysplastic syndrome, which he states has "established efficacy in both patient populations." Messer further contends that big pharma passing on imetelstat does not reflect a fundamental issue with the drug itself.
04/09/19
PIPR
04/09/19
NO CHANGE
Target $32
PIPR
Neutral
Alkermes' ALPINE data an incremental positive, says Piper Jaffray
After Alkermes (ALKS) reported this morning that its ALPINE trial met its primary endpoint and that Aristada showed similar efficacy to the current market leader, Invega Sustenna, at all time points assessed, Piper Jaffray analyst Danielle Brill said she views the data as an incremental positive. However, she thinks it will be challenging to capture share from Johnson & Johnson (JNJ), telling investors that she is "not sure these data will be enough to move the needle." Brill maintains a Neutral rating on Alkermes.

TODAY'S FREE FLY STORIES

NXPI

NXP Semiconductors

$90.85

-2.79 (-2.98%)

14:45
05/23/19
05/23
14:45
05/23/19
14:45
Options
NXP Semiconductors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 13

    Jun

FE

FirstEnergy

$42.94

0.31 (0.73%)

14:36
05/23/19
05/23
14:36
05/23/19
14:36
Periodicals
Breaking Periodicals news story on FirstEnergy »

Ohio advances bill that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$202.83

-6.34 (-3.03%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Hot Stocks
Huntington Ingalls VP William Ermatinger sells almost $400K in company shares »

Huntington Ingalls VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

QRVO

Qorvo

$59.38

-0.83 (-1.38%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Options
Qorvo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UIS

Unisys

$9.44

-0.3 (-3.08%)

14:31
05/23/19
05/23
14:31
05/23/19
14:31
Initiation
Unisys initiated  »

Unisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MAXR

Maxar Technologies

$8.20

1.05 (14.69%)

14:28
05/23/19
05/23
14:28
05/23/19
14:28
Hot Stocks
NASA confirms contract with maximum $375M value awarded to Maxar Technologies »

NASA announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$40.84

-0.86 (-2.06%)

, PLD

Prologis

$76.02

-0.55 (-0.72%)

14:27
05/23/19
05/23
14:27
05/23/19
14:27
Periodicals
Blackstone, Prologis separately bidding for U.S. unit of GLP, WSJ says »

Blackstone (BX) and…

BX

Blackstone

$40.84

-0.86 (-2.06%)

PLD

Prologis

$76.02

-0.55 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

GLNG

Golar LNG

$19.17

-0.82 (-4.10%)

14:25
05/23/19
05/23
14:25
05/23/19
14:25
Options
Golar LNG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$107.68

-3.11 (-2.81%)

14:24
05/23/19
05/23
14:24
05/23/19
14:24
Periodicals
JPMorgan severs ties with OxyContin maker Purdue Pharma, Reuters says »

JPMorgan has severed ties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

MAXR

Maxar Technologies

$8.04

0.89 (12.45%)

14:18
05/23/19
05/23
14:18
05/23/19
14:18
Hot Stocks
Breaking Hot Stocks news story on Maxar Technologies »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
05/23/19
05/23
14:17
05/23/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$53.15

-1.05 (-1.94%)

14:16
05/23/19
05/23
14:16
05/23/19
14:16
Recommendations
Foot Locker analyst commentary at Canaccord »

Canaccord says buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
05/23/19
05/23
14:16
05/23/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
05/23/19
05/23
14:15
05/23/19
14:15
Conference/Events
Wolfe Research pharmaceuticals analyst to hold analyst/industry conference call »

Pharmaceuticals Analyst…

VXX

iPath S&P 500 VIX Short-Term Futures

$29.12

1.91 (7.02%)

14:10
05/23/19
05/23
14:10
05/23/19
14:10
Options
Bullish spread opened in VIX Short-term Futures Fund »

Bullish spread opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:06
05/23/19
05/23
14:06
05/23/19
14:06
Conference/Events
Wolfe Research managing director to hold an analyst/industry webinar »

Quantitative Analysis,…

MAXR

Maxar Technologies

$7.59

0.44 (6.15%)

14:06
05/23/19
05/23
14:06
05/23/19
14:06
Hot Stocks
Maxar Technologies up 17% after selection for NASA project »

Maxar Technologies shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLUU

Glu Mobile

$8.32

-0.185 (-2.18%)

14:05
05/23/19
05/23
14:05
05/23/19
14:05
Options
Glu Mobile call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 13

    Nov

MAXR

Maxar Technologies

$7.32

0.17 (2.38%)

14:03
05/23/19
05/23
14:03
05/23/19
14:03
Periodicals
NASA selects Maxar for first part of lunar gateway, WFTV reports »

Maxar Technologies was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$40.90

-0.8 (-1.92%)

, PLD

Prologis

$76.22

-0.35 (-0.46%)

14:00
05/23/19
05/23
14:00
05/23/19
14:00
Periodicals
Breaking Periodicals news story on Blackstone, Prologis »

Blackstone, Prologis bid…

BX

Blackstone

$40.90

-0.8 (-1.92%)

PLD

Prologis

$76.22

-0.35 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

BX

Blackstone

$40.90

-0.8 (-1.92%)

, PLD

Prologis

$76.22

-0.35 (-0.46%)

13:59
05/23/19
05/23
13:59
05/23/19
13:59
Periodicals
Breaking Periodicals news story on Blackstone, Prologis »

Blackstone, Prologis…

BX

Blackstone

$40.90

-0.8 (-1.92%)

PLD

Prologis

$76.22

-0.35 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

MAXR

Maxar Technologies

$7.00

-0.15 (-2.10%)

13:56
05/23/19
05/23
13:56
05/23/19
13:56
Periodicals
Breaking Periodicals news story on Maxar Technologies »

Maxar selected by NASA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$37.86

-0.96 (-2.47%)

13:55
05/23/19
05/23
13:55
05/23/19
13:55
Options
Taiwan Semi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BB

BlackBerry

$8.05

-0.26 (-3.13%)

13:45
05/23/19
05/23
13:45
05/23/19
13:45
Options
BlackBerry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
05/23/19
05/23
13:45
05/23/19
13:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.